Receive market access case studies from MSD, Sanofi, GSK and more

LONDON - Sept. 24, 2015 - PRLog -- SMi’s 21st annual European Pharmaceutical Pricing & Reimbursement conference, taking place on 5th - 6th October 2015 in London, will provide the ideal platform for payers and other decision makers from both public and private organisations, to benchmark with peers internationally and provide pharma companies with an invaluable insight into the decision making processes and approaches of vital stakeholders.

The two-day conference programme will help further your understanding and enable you to develop best practice approaches to complex market access challenges - with the ultimate goal of encouraging innovation and improving patient access to novel and powerful medications though case studies presented by GSK, Sanofi, MSD and more, who will be presenting at the two-day conference. Unique perspectives will be provided on:
• The impact of Biosimilars and Orphan Drugs on the the market with case studies from MSD and Quintiles
• Tiered pricing options with a case study from GSK
• Case studies in Reforms with Sanofi sharing their recent experience
• New models for European reimbursement
• Health Technology Assessment policies
• Changes in UK P&R policy following the UK elections with presentations from industry bodies such as EMIG and the ABPI

Receive market access case studies at the industry established conference on European Pharmaceutical Pricing & Reimbursement from MSD, Sanofi and GSK:

• Analysing the characteristics of biosimilars and the development of the EU’s biosimilars market
Alexander Roediger, Director of European Union Affairs, MSD

• Tiered Pricing
Ken Walsh, Head of Emerging Markets Pricing, GSK

• Market Access in Turkey: Risks and opportunities in the post Healthcare Transformation Era
Toros Sahin, Head of Market Access & Health Economics, Sanofi

View the full speaker line-up, two-day conference programme and download the 2015 attendee list at http://www.smi-online.co.uk/2015europricing1.asp